We age because our bodies accumulate damage faster than they can repair it. Every cell in your body faces a constant barrage of threats, from copying errors in DNA to toxic byproducts of normal metabolism, and over decades the repair systems themselves wear down. There is no single cause of aging. Instead, at least nine interconnected biological processes drive the decline, each feeding into the others in ways that accelerate over time.
Your DNA Accumulates Damage Over a Lifetime
Every day, each of your cells sustains tens of thousands of DNA lesions. Ultraviolet light, environmental toxins, and even normal cell chemistry cause point mutations, chromosomal breaks, and other forms of genetic damage. Your body has sophisticated repair machinery to fix most of this, but it’s not perfect. Over decades, errors slip through and accumulate, disrupting the genes cells need to function properly.
This slow buildup of genetic damage is considered the most fundamental driver of aging. It affects not just the DNA in your cell nuclei but also the small, separate genome inside your mitochondria, the structures that produce energy for every cell. Mitochondrial DNA is especially vulnerable because it sits right next to the chemical reactions that generate energy, and it lacks some of the protective mechanisms that shield nuclear DNA.
Telomeres Set a Limit on Cell Division
At the tips of your chromosomes sit protective caps called telomeres. Each time a cell divides, these caps get slightly shorter. When they become critically short, the cell can no longer divide safely. Human cells typically hit this wall after 40 to 80 divisions, a boundary known as the Hayflick limit. An enzyme called telomerase can rebuild telomeres, but most adult cells produce very little of it. Stem cells and immune cells make more, which is why they can keep dividing longer, but even they lose ground over the years.
Telomere shortening acts as a built-in countdown clock. It protects you from cancer by preventing damaged cells from dividing endlessly, but the tradeoff is that tissues gradually lose their ability to regenerate. Skin heals more slowly, the immune system weakens, and organs lose functional capacity.
Zombie Cells That Refuse to Die
When a cell’s DNA is too damaged to repair, or its telomeres are too short, it normally faces two options: self-destruct or enter a permanent state of retirement called senescence. Senescent cells stop dividing but don’t die. They linger in your tissues, and they’re far from quiet. These “zombie cells” pump out inflammatory signals, most notably a protein called interleukin-6, along with other molecules that damage surrounding healthy tissue and push neighboring cells toward senescence too.
In young people, the immune system clears senescent cells efficiently. With age, they accumulate faster than the body can remove them. The chronic, low-grade inflammation they generate is now considered a major contributor to heart disease, arthritis, diabetes, and cognitive decline. This background inflammation is so closely linked to aging that researchers sometimes call it “inflammaging.”
Your Cellular Power Plants Break Down
Mitochondria generate the energy your cells need to function, but the process is inherently messy. It produces reactive oxygen species, commonly called free radicals, as a byproduct. These highly reactive molecules damage proteins, fats, and DNA, including the mitochondria’s own DNA.
This creates a vicious cycle. Damaged mitochondrial DNA impairs the energy-production machinery, which causes the mitochondria to leak even more free radicals, which cause further damage. Over time, cells produce less energy and accumulate more waste. The free radical theory of aging, first proposed more than fifty years ago, remains one of the most studied explanations for why tissues deteriorate. Research consistently finds higher levels of oxidative DNA damage in aged tissues compared to young ones.
Proteins Lose Their Shape
Your cells constantly build, fold, and recycle proteins. Each protein must fold into a precise three-dimensional shape to work correctly. As you age, the quality-control systems that ensure proper folding and clear out misfolded proteins become less effective. Damaged or clumped proteins start to build up inside cells.
This breakdown in protein maintenance is especially damaging in the brain, where long-lived neurons are particularly vulnerable. The sticky protein plaques seen in Alzheimer’s disease and the protein clumps found in Parkinson’s disease are direct consequences of this failing cleanup system. Research shows that degradation pathways for clearing defective proteins become impaired with age, and once they do, the accumulation of toxic aggregates accelerates.
Your Body’s Growth Signals Get Stuck
Cells constantly monitor the nutrients available to them and adjust their behavior accordingly. One of the most important regulators is a signaling pathway called mTOR, which acts like a master switch for cell growth. When nutrients are abundant, mTOR tells cells to grow, build proteins, and divide. When nutrients are scarce, cells shift into a more conservative mode, recycling damaged components and repairing themselves.
The problem is that in modern life, with consistent food availability, this growth pathway tends to stay chronically active. Overactive mTOR signaling suppresses autophagy, the cellular recycling process that clears out damaged parts. This is one reason caloric restriction extends lifespan in laboratory animals: reducing nutrient intake dials down mTOR, allowing cells to spend more time on maintenance and repair. Suppressing mTOR in animal studies not only extends lifespan but restores more youthful function in organs like the heart.
Stem Cells Run Out of Steam
Your body relies on stem cells to replenish tissues throughout life. They replace blood cells, repair injured muscle, regenerate the gut lining, and maintain skin. But stem cells are subject to all the same damage as other cells. Their DNA accumulates mutations, their telomeres shorten, and the signals from their environment become increasingly inflammatory. Over time, stem cells either die, become senescent, or simply stop responding to repair signals as effectively.
The result is visible everywhere in an aging body. Wounds heal more slowly. The immune system produces fewer fresh cells to fight infections. Muscle mass declines because satellite cells, the stem cells responsible for muscle repair, become less active. Hair turns gray because the stem cells that produce pigment-generating cells in hair follicles gradually fail.
Why Evolution Allows Aging to Happen
From an evolutionary standpoint, aging exists because natural selection cares most about reproduction. A gene that helps you survive to reproductive age and produce healthy offspring will be favored, even if that same gene causes harm later in life. This concept, called antagonistic pleiotropy, explains why the body isn’t built to last indefinitely.
The high levels of growth hormones and inflammatory responses that help a young body develop quickly and fight off infections can, decades later, promote cancer and chronic disease. Evolution never “designed” a solution to aging because, in the wild, most animals die from predation, starvation, or disease long before old age becomes relevant. There was simply no evolutionary pressure to build bodies that last 100 years. Modern molecular biology has identified hundreds of genes that, when modified in laboratory animals, can extend lifespan, suggesting aging is not a fixed, inevitable program but a collection of tradeoffs that could, in principle, be altered.
How Long Can Humans Actually Live?
Despite improvements in medicine and sanitation, there appears to be a ceiling on human lifespan. The oldest verified person, Jeanne Calment, died at 122. But she is a dramatic outlier. Statistical analysis of global mortality data shows that the maximum reported age at death has plateaued at roughly 115 years. The probability of anyone exceeding 125 in a given year is estimated at less than 1 in 10,000. While average life expectancy has risen sharply over the past century, mostly by reducing early-life deaths from infection and malnutrition, the upper boundary has barely budged.
Measuring How Fast You’re Actually Aging
Your chronological age (how many birthdays you’ve had) doesn’t always match your biological age (how worn your cells actually are). Scientists now measure biological age using “epigenetic clocks,” which analyze chemical tags on your DNA called methylation marks. These tags change in predictable patterns as you age, and machine learning algorithms can read them like a molecular odometer.
The best-performing epigenetic clocks correlate strongly with chronological age in blood samples, though accuracy varies by tissue type. The practical value is in the gap between your predicted biological age and your actual age. People whose biological age runs ahead of their chronological age face higher risks of age-related disease and earlier mortality, while those who clock in younger biologically tend to stay healthier longer. Lifestyle factors like exercise, diet, sleep, and stress management all influence where you fall on that spectrum.
Clearing Zombie Cells in Humans
One of the most promising areas in aging research involves drugs that selectively kill senescent cells, called senolytics. The most studied combination pairs a cancer drug called dasatinib with quercetin, a compound found naturally in onions and apples. Together, they’ve been shown to clear senescent cells in both cell cultures and animal models, and they’ve now entered human clinical trials for conditions including Alzheimer’s disease, diabetic kidney disease, and a scarring lung condition called idiopathic pulmonary fibrosis.
Early trial results have focused primarily on safety rather than dramatic rejuvenation, but the concept represents a real shift in how medicine approaches aging. Rather than treating each age-related disease separately, senolytics target one of the underlying processes that drives many of them simultaneously. Whether this approach will meaningfully extend healthy human lifespan remains an open question, but it marks the first time therapies are being tested that go after the biology of aging itself.